Bioventus Inc. (NASDAQ:BVS) is one of the best medical device stocks to buy according to analysts. On August 7, Craig-Hallum analyst Chase Knickerbocker reiterated a Buy rating on Bioventus Inc. (NASDAQ:BVS) and set a price target of $15.00.
A doctor repairing a foot and ankle injury using the latest sports medicine techniques.
The analyst gave the rating after Bioventus Inc. reported its fiscal Q2 results on August 6, with reported revenue of $147.7 million declining 2.4% and organic revenue advancing 6.2%.
Diluted earnings per share for Q2 was $0.11 compared to a diluted loss per share of $0.40 in the prior-year period.
Bioventus Inc. also reported cash from operations of $25.9 million and non-GAAP earnings of $0.21 per share.
Bioventus Inc. is a medical technology company that develops and commercializes proprietary orthobiologic products to treat musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
